Plain-English translation of NCT06809166 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Obesity research guide →Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
Researchers want to understand how —a weight loss medication combining two active ingredients—affects your brain function, metabolism, and eating behaviors when combined with a structured diet program. This is a pilot study, meaning it's designed to gather early information about how the medication works in people with obesity. Half of the participants will receive the medication plus diet support, and half will receive a placebo (dummy pill) plus the same diet support.
While this medication is already approved and used for weight loss, doctors don't fully understand all the ways it works in the body and brain. This trial aims to identify the underlying mechanisms that may explain why the medication helps people lose weight, which could improve future weight loss treatments.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to receive either the medication or a placebo—both combined with a structured diet program—over a short period. You'll attend multiple in-person visits at the research laboratory for screening, baseline testing, and follow-up assessments. During these visits, you may complete brain imaging scans, answer questions about your eating habits and mood, provide blood samples, and undergo metabolic testing to measure how your body processes energy.
AI-generated summary from trial data · Jul 1, 2026 · Not medical advice
Canada